Maintenance avelumab 'new standard of care' for advanced urothelial cancer

… vs 2.6%), anemia (3.8 vs 2.9%), hematuria (1.7 vs 1.4%), fatigue (1.7 vs 0.6%), and back pain (1.2 vs 2.3%) the most common events of this severity.
Source: back pain